Can Psychodrama Improve Aggressive Behavior and Social Adaptation in Adolescent Boys?
NCT ID: NCT07311174
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2023-03-05
2023-07-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Therapy for Children and Adolescents With Tourette Syndrome
NCT03621059
Early Adolescent Skills for Emotions (EASE)-Pilot Cluster Randomized Controlled Trial (cRCT) in Public Schools of Rural Pakistan
NCT04254393
The Therapeutic Effects of Barkley's Parenting Management Program for Taiwanese School-Aged Children With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00946582
Evaluation of Right To Play's Positive Child and Youth Development Program in Middle Schools in Hyderabad, Pakistan
NCT03448523
Behavior Therapy for Irritability in Autism
NCT04654260
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Twenty-two students meeting eligibility criteria were randomly assigned in a 1:1 ratio to either the psychodrama intervention group (n=11) or the comparison group (n=11). One participant in the intervention group dropped out, resulting in final analysis of 21 participants.
The intervention consisted of 10 weekly 90-minute psychodrama sessions based on Blatner's protocol, including role-playing, mirroring, soliloquy, storytelling, future projection, and relaxation exercises. The comparison group received no intervention during the study period but was offered the program after study completion.
Primary outcomes were aggression (measured by BPAQ) and social adjustment (measured by BAI), assessed at baseline and post-intervention. Data were analyzed using ANCOVA and repeated measures ANOVA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Psychodrama
Participants received a 10-session structured psychodrama intervention based on Blatner's protocol. Sessions were held weekly for 90 minutes.
Psychodrama
Participants received a 10-session structured psychodrama intervention based on Blatner's protocol. Sessions were held weekly for 90 minutes.
Standard school program
Participants continued with their standard school educational program. They received no additional sessions, therapy, or intervention during the 10-week study period.
Other: Standard Care
Control
The control group recieved no intervention during 10 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychodrama
Participants received a 10-session structured psychodrama intervention based on Blatner's protocol. Sessions were held weekly for 90 minutes.
Control
The control group recieved no intervention during 10 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BPAQ score \> 117.
* BAI score between 16 and 20.
* Able to commute to after-school classes.
* Parental informed consent obtained.
Exclusion Criteria
* History of major psychiatric disorders or current psychiatric medication use.
* Unwillingness to participate or missing \>2 sessions.
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kerman University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Parvin Rezaei-Gazki
faculty member
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kerman University of Medical Sciences
Kerman, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IR.IAU.BA.REC.1402.049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.